Paper3765601
Antihypertensive therapy, serum lipids, coronary heart disease and hypertension--balancing the risks and benefits of treatment.
Houston MC. West J Med, 1986. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Antihypertensive therapy, serum lipids, coronary heart disease and hypertension--balancing the risks and benefits of treatment. Papers, record 3765601. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3765601
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Antihypertensive therapy, serum lipids, coronary heart disease and hypertension--balancing the risks and benefits of treatment.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Coronary Disease | Major topic |
| Hypertension | Major topic |
| Lipids | Major topic |
| Adult | |
| Antihypertensive Agents | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Risk |
Source PubMed
References27
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4403533 | A primary preventive study of Gothenburg, Sweden. | Prev Med | 1972 | https://conductscience.org/library/papers/4403533 | PubMed |
| 2 | 14485566 | The effect of oral hydralazine on circulating human cholesterol. | Am J Med Sci | 1962 | https://conductscience.org/library/papers/14485566 | PubMed |
| 3 | 796642 | Optimal dose of a thiazide diuretic. | Med J Aust | 1976 | https://conductscience.org/library/papers/796642 | PubMed |
| 4 | 140029 | Treatment of mild hypertension: results of a ten-year intervention trial. | Circ Res | 1977 | https://conductscience.org/library/papers/140029 | PubMed |
| 5 | 361988 | Prazosin and clonidine for moderately severe hypertension. | JAMA | 1978 | https://conductscience.org/library/papers/361988 | PubMed |
| 6 | 7001898 | Treatment of mild hypertension: a five year controlled drug trial. The Oslo study. | Am J Med | 1980 | https://conductscience.org/library/papers/7001898 | PubMed |
| 7 | 7447225 | Effects of thiazide diuretics on plasma lipids and lipoproteins in mildly hypertensive patients: a double-blind controlled trial. | Ann Intern Med | 1981 | https://conductscience.org/library/papers/7447225 | PubMed |
| 8 | 7037030 | Oxprenolol, methyldopa and lipids in diabetes mellitus. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7037030 | PubMed |
| 9 | 6177958 | Antihypertensive therapy and the risk of coronary heart disease. | J Cardiovasc Pharmacol | 1982 | https://conductscience.org/library/papers/6177958 | PubMed |
| 10 | 6177962 | Effect of prazosin on serum lipids. | J Cardiovasc Pharmacol | 1982 | https://conductscience.org/library/papers/6177962 | PubMed |
| 11 | 6869207 | Some wrong-way chemical changes during antihypertensive treatment: comparison of indapamide and related agents. | Am Heart J | 1983 | https://conductscience.org/library/papers/6869207 | PubMed |
| 12 | 6367446 | Effects of long-term prazosin therapy on lipoprotein metabolism in hypertensive patients. | Am J Med | 1984 | https://conductscience.org/library/papers/6367446 | PubMed |
| 13 | 6702863 | Effects of diuretic and beta-blocker therapy in the Medical Research Council Trial. | Am J Med | 1984 | https://conductscience.org/library/papers/6702863 | PubMed |
| 14 | 6712367 | Serum cholesterol during treatment of hypertension with diuretic drugs. | Arch Intern Med | 1984 | https://conductscience.org/library/papers/6712367 | PubMed |
| 15 | 6327117 | Optimal resources for primary prevention of atherosclerotic diseases. Atherosclerosis Study Group. | Circulation | 1984 | https://conductscience.org/library/papers/6327117 | PubMed |
| 16 | 6744774 | Serum lipids in normo- and hyperlipidemics after methyldopa and propranolol. | Clin Pharmacol Ther | 1984 | https://conductscience.org/library/papers/6744774 | PubMed |
| 17 | 6084135 | Antihypertensive treatment: cardiovascular risks and monotherapy. | J Cardiovasc Pharmacol | 1984 | https://conductscience.org/library/papers/6084135 | PubMed |
| 18 | 6084137 | Effects of guanabenz on plasma lipid levels in hypertensive patients. | J Cardiovasc Pharmacol | 1984 | https://conductscience.org/library/papers/6084137 | PubMed |
| 19 | 2859784 | Effect of beta blockers on blood lipid profile. | Am Heart J | 1985 | https://conductscience.org/library/papers/2859784 | PubMed |
| 20 | 2860883 | Antihypertensive therapy and lipids. Evidence, mechanisms, and implications. | Arch Intern Med | 1985 | https://conductscience.org/library/papers/2860883 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 32042057 | Nuclear Translocation of Glutaminase GLS2 in Human Cancer Cells Associates with Proliferation Arrest and Differentiation. | Sci Rep | 2020 | https://conductscience.org/library/papers/32042057 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3765601
GET https://conductscience.org/api/papers/v1/3765601/references?page=2